ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 960

Autoantibodies in Rheumatoid Arthritis Target Citrulline-Containing and Native Epitopes from Conformationally Disordered Regions of Proteins

Zihao Zheng 1, Lauren Fahmy 1, Alan Bridges 2, Michael Newton 1 and Miriam Shelef1, 1University of Wisconsin - Madison, Madison, 2William S. Middleton Memorial Veterans Hospital, Madison

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: anti-citrullinated protein/peptide antibodies (ACPA) and autoantibodies, Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: B Cell Biology & Targets In Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are the main diagnostic and pathologic autoantibodies in rheumatoid arthritis. However, autoantibodies develop against proteins with other post-translational modifications, such as homocitrullination, as well as against various native proteins without obvious unifying characteristics of the antigens. Moreover, some rheumatoid arthritis patients generate only RF or only ACPAs (as detected by the anti-cyclic citrullinated peptide (CCP) test) and some produce neither. We have a poor understanding of the autoantibody repertoire in these patients. Our objective was to broadly evaluate autoantibody binding in seronegative and seropositive rheumatoid arthritis to identify general and novel features of autoantibody reactivity.

Methods: An array was created with 172,828 overlapping peptides derived from 122 proteins citrullinated in the rheumatoid joint including variants with arginines or lysines replaced with citrullines or homocitrullines, respectively. IgG and IgM binding to peptides was compared for CCP+RF+, CCP+RF-, CCP-RF+, and CCP-RF- rheumatoid arthritis versus controls. Highly bound peptides were analyzed for amino acid patterns and predictors of structural disorder. Published synovial fluid citrullinomes were also analyzed for amino acid patterns.

Results: Broadly, CCP+RF+ subjects had very high and CCP+RF- and CCP-RF+ subjects had modest citrulline-specific IgG binding. All rheumatoid arthritis groups had low homocitrulline-specific IgG binding and CCP+RF+ subjects had high IgG binding to native peptides. CCP-RF- subjects had very little antibody binding in general. By far, the highest IgG binding in rheumatoid arthritis was to citrulline-containing peptides, irrespective of protein identity, especially if the citrulline was adjacent to glycine or serine. Citrullinated arginines in the rheumatoid joint were also frequently next to glycine and serine. The most highly bound citrulline-containing and native peptides had multiple features predictive of conformational disorder.

Conclusion: In general, we observed a continuum of autoantibody binding in rheumatoid arthritis with a very high amount of binding in CCP+RF+ subjects, modest binding in CCP+RF- and CCP-RF+ subjects, and very little binding in CCP-RF- subjects. Further, citrulline, particularly next to serine or glycine, is a major driver of autoantibody reactivity in rheumatoid arthritis, likely due in part to frequent in vivo citrullination of arginine next to serine or glycine. Finally, structural disorder may be a newly discovered feature that drives rheumatoid arthritis autoantibodies.


Disclosure: Z. Zheng, None; L. Fahmy, None; A. Bridges, None; M. Newton, None; M. Shelef, None.

To cite this abstract in AMA style:

Zheng Z, Fahmy L, Bridges A, Newton M, Shelef M. Autoantibodies in Rheumatoid Arthritis Target Citrulline-Containing and Native Epitopes from Conformationally Disordered Regions of Proteins [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/autoantibodies-in-rheumatoid-arthritis-target-citrulline-containing-and-native-epitopes-from-conformationally-disordered-regions-of-proteins/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/autoantibodies-in-rheumatoid-arthritis-target-citrulline-containing-and-native-epitopes-from-conformationally-disordered-regions-of-proteins/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology